Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1082 | 2762 | 41.6 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
276 | 18466 | BREAST CANCER//ACCELERATED PARTIAL BREAST IRRADIATION//PARTIAL BREAST IRRADIATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ONCOTYPE DX | Author keyword | 78 | 83% | 2% | 44 |
2 | TRIPLE NEGATIVE BREAST CANCER | Author keyword | 77 | 31% | 8% | 209 |
3 | TRIPLE NEGATIVE | Author keyword | 73 | 39% | 5% | 146 |
4 | RECURRENCE SCORE | Author keyword | 64 | 88% | 1% | 30 |
5 | BASAL LIKE | Author keyword | 53 | 54% | 2% | 68 |
6 | 70 GENE SIGNATURE | Author keyword | 24 | 91% | 0% | 10 |
7 | MAMMAPRINT | Author keyword | 23 | 79% | 1% | 15 |
8 | ONCOTYPE DX R | Author keyword | 21 | 90% | 0% | 9 |
9 | BASAL LIKE BREAST CANCER | Author keyword | 21 | 40% | 1% | 40 |
10 | PAM50 | Author keyword | 21 | 85% | 0% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCOTYPE DX | 78 | 83% | 2% | 44 | Search ONCOTYPE+DX | Search ONCOTYPE+DX |
2 | TRIPLE NEGATIVE BREAST CANCER | 77 | 31% | 8% | 209 | Search TRIPLE+NEGATIVE+BREAST+CANCER | Search TRIPLE+NEGATIVE+BREAST+CANCER |
3 | TRIPLE NEGATIVE | 73 | 39% | 5% | 146 | Search TRIPLE+NEGATIVE | Search TRIPLE+NEGATIVE |
4 | RECURRENCE SCORE | 64 | 88% | 1% | 30 | Search RECURRENCE+SCORE | Search RECURRENCE+SCORE |
5 | BASAL LIKE | 53 | 54% | 2% | 68 | Search BASAL+LIKE | Search BASAL+LIKE |
6 | 70 GENE SIGNATURE | 24 | 91% | 0% | 10 | Search 70+GENE+SIGNATURE | Search 70+GENE+SIGNATURE |
7 | MAMMAPRINT | 23 | 79% | 1% | 15 | Search MAMMAPRINT | Search MAMMAPRINT |
8 | ONCOTYPE DX R | 21 | 90% | 0% | 9 | Search ONCOTYPE+DX+R | Search ONCOTYPE+DX+R |
9 | BASAL LIKE BREAST CANCER | 21 | 40% | 1% | 40 | Search BASAL+LIKE+BREAST+CANCER | Search BASAL+LIKE+BREAST+CANCER |
10 | PAM50 | 21 | 85% | 0% | 11 | Search PAM50 | Search PAM50 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOLECULAR PORTRAITS | 107 | 38% | 8% | 223 |
2 | BASAL LIKE SUBTYPE | 104 | 54% | 5% | 136 |
3 | 21 GENE RECURRENCE SCORE | 89 | 90% | 1% | 38 |
4 | PROGNOSTIC SIGNATURE | 85 | 72% | 2% | 67 |
5 | MOLECULAR SUBTYPES | 73 | 37% | 6% | 157 |
6 | INTERNATIONAL EXPERT CONSENSUS | 72 | 39% | 5% | 145 |
7 | 70 GENE PROGNOSIS SIGNATURE | 51 | 83% | 1% | 29 |
8 | RECURRENCE SCORE ASSAY | 48 | 91% | 1% | 20 |
9 | ONCOTYPE DX | 41 | 85% | 1% | 22 |
10 | MINDACT TRIAL | 37 | 67% | 1% | 34 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Subtyping of Triple-Negative Breast Cancer: Implications for Therapy | 2015 | 5 | 41 | 49% |
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence | 2015 | 2 | 57 | 93% |
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer | 2009 | 550 | 83 | 67% |
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow | 2014 | 20 | 90 | 84% |
Triple-Negative Breast Cancer | 2010 | 454 | 57 | 60% |
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes | 2014 | 33 | 59 | 41% |
New treatment strategies for patients with triple-negative breast cancer | 2015 | 2 | 32 | 59% |
Radiation therapy in the locoregional treatment of triple-negative breast cancer | 2015 | 2 | 76 | 51% |
3 Multigene prognostic tests in breast cancer: past, present, future | 2015 | 1 | 31 | 87% |
Clinical application of the 70-gene profile: The MINDACT trial | 2008 | 233 | 20 | 95% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VERIDEX LLC | 8 | 62% | 0.3% | 8 |
2 | TRANSLAT FUNCT GENOM UNIT | 6 | 80% | 0.1% | 4 |
3 | DIAGNOST ONCOL | 5 | 20% | 0.8% | 23 |
4 | INT BREAST CANC STUDY GRP | 5 | 30% | 0.5% | 13 |
5 | FUNCT BREAST CANC GENOM | 4 | 75% | 0.1% | 3 |
6 | HOSP PRATO | 4 | 75% | 0.1% | 3 |
7 | GOVERNANCE MANAGEMENT | 4 | 56% | 0.2% | 5 |
8 | TRANSLAT GENOM GRP | 4 | 35% | 0.3% | 9 |
9 | NOTTINGHAM CITY HOSP NHS TRUST | 4 | 33% | 0.3% | 9 |
10 | TRANSLAT UNIT | 4 | 11% | 1.1% | 31 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000137076 | HER 2//HER2 TESTING//POLYSOMY 17 |
2 | 0.0000129144 | VERY YOUNG WOMEN//YOUNG BREAST CANCER//YOUNG AGE |
3 | 0.0000124369 | INFLAMMATORY BREAST CANCER//NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER |
4 | 0.0000116073 | PERITUMORAL VASCULAR INVASION//BLOOD VESSEL INVASION//AXILLARY NODE STATUS |
5 | 0.0000092660 | OLAPARIB//SYNTHETIC LETHALITY//PARP INHIBITOR |
6 | 0.0000091614 | PHILIP MORRIS INT RD//COMPUTAT PL GENOM PROGRAM//SECT COMPUTAT BIOMED |
7 | 0.0000085202 | INTERACTION CONDITION//TARGETED CLINICAL TRIALS//INFLUENCE CONDITION |
8 | 0.0000084303 | MAMMAGLOBIN//MAMMAGLOBIN A//HUMAN MAMMAGLOBIN |
9 | 0.0000078954 | DIFFERENTIAL GENE EXPRESSION DETECTION//CANCER OUTLIER PROFILE ANALYSIS//BREAST CANC DIAG TREATMENT HENAN |
10 | 0.0000075009 | ZNF703//C8ORF4//8P12 |